Clinical phenotypes and genetic features of epilepsy children with MBD5 gene variants

Objective: To summarize the phenotypes of epilepsy in patients with MBD5 gene variants. Methods: A total of 9 epileptic patients, who were treated in the Department of Pediatrics, Peking University First Hospital from July 2016 to September 2021 and detected with MBD5 gene pathogenic variants, were...

Description complète

Détails bibliographiques
Publié dans:Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 60(2022), 4 vom: 02. Apr., Seite 345-349
Auteur principal: Jing, X W (Auteur)
Autres auteurs: Cheng, M M, Niu, X Y, Yang, Y, Yang, X L, Yang, Z X, Zhang, Y H
Format: Article en ligne
Langue:Chinese
Publié: 2022
Accès à la collection:Zhonghua er ke za zhi = Chinese journal of pediatrics
Sujets:Journal Article DNA-Binding Proteins MBD5 protein, human Nucleotides
LEADER 01000caa a22002652c 4500
001 NLM339156880
003 DE-627
005 20250303054023.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||chi c
024 7 |a 10.3760/cma.j.cn112140-20211015-00874  |2 doi 
028 5 2 |a pubmed25n1130.xml 
035 |a (DE-627)NLM339156880 
035 |a (NLM)35385942 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Jing, X W  |e verfasserin  |4 aut 
245 1 0 |a Clinical phenotypes and genetic features of epilepsy children with MBD5 gene variants 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 08.04.2022 
500 |a Date Revised 31.05.2022 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Objective: To summarize the phenotypes of epilepsy in patients with MBD5 gene variants. Methods: A total of 9 epileptic patients, who were treated in the Department of Pediatrics, Peking University First Hospital from July 2016 to September 2021 and detected with MBD5 gene pathogenic variants, were enrolled. The features of clinical manifestations, electroencephalogram (EEG), and neuroimaging were analyzed retrospectively. Results: Among 9 patients, 6 were male and 3 were female. Age at seizure onset ranged from 5 to 89 months. Multiple seizure types were observed, including generalized tonic clonic seizures (GTCS) in 7 patients, myoclonic seizures in 5 patients, focal seizures in 5 patients, atypical absence seizures in 3 patients, atonic seizures in 2 patients, myoclonus absence seizures in 1 patient, epileptic spasms in 1 patient, and tonic seizures in 1 patient. There were 8 patients with multiple seizure types, 2 patients with sensitivity to fever and 5 patients with clustering of seizures. Two patients had a history of status epilepticus. All patients had developmental delay before seizure onset. Nine patients had obvious language delay, and 6 patients had autism-like manifestations. Five patients had slow background activity in EEG. Interictal EEG showed abnormal discharges in 9 patients. Brain magnetic resonance imaging (MRI) was normal in all patients. A total of 9 epileptic patients carried MBD5 gene variants, all of them were de novo variants. There were MBD5 gene overall heterozygous deletion in 1 patient, large fragment deletions including MBD5 gene in 3 patients and single nucleotide variations (c.300C>A/p.C100X, c.1775delA/p.N592Tfs*29, c.1759C>T/p.Q587X, c.150_151del/p.Lys51Asnfs*6, c.113+1G>C) in 5 patients. The age at last follow-up ranged from 2 years and 9 months to 11 years and 11 months. At the last follow-up, 2 patients were seizure-free for more than 11 months to 4 years 6 months, 7 patients still had seizures. Conclusions: The initial seizure onset in patients with MBD5 gene variants usually occurs in infancy. Most patients have multiple seizure types. The seizures may be fever sensitive and clustered. Developmental delays, language impairments, and autistic behaviors are common. MBD5 gene variants include single nucleotide variations and fragment deletions. Epilepsy associated with MBD5 gene variants is usually refractory 
650 4 |a Journal Article 
650 7 |a DNA-Binding Proteins  |2 NLM 
650 7 |a MBD5 protein, human  |2 NLM 
650 7 |a Nucleotides  |2 NLM 
700 1 |a Cheng, M M  |e verfasserin  |4 aut 
700 1 |a Niu, X Y  |e verfasserin  |4 aut 
700 1 |a Yang, Y  |e verfasserin  |4 aut 
700 1 |a Yang, X L  |e verfasserin  |4 aut 
700 1 |a Yang, Z X  |e verfasserin  |4 aut 
700 1 |a Zhang, Y H  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhonghua er ke za zhi = Chinese journal of pediatrics  |d 1960  |g 60(2022), 4 vom: 02. Apr., Seite 345-349  |w (DE-627)NLM136249191  |x 0578-1310  |7 nnas 
773 1 8 |g volume:60  |g year:2022  |g number:4  |g day:02  |g month:04  |g pages:345-349 
856 4 0 |u http://dx.doi.org/10.3760/cma.j.cn112140-20211015-00874  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_20 
912 |a GBV_ILN_22 
912 |a GBV_ILN_24 
912 |a GBV_ILN_31 
912 |a GBV_ILN_39 
912 |a GBV_ILN_40 
912 |a GBV_ILN_50 
912 |a GBV_ILN_61 
912 |a GBV_ILN_65 
912 |a GBV_ILN_69 
912 |a GBV_ILN_70 
912 |a GBV_ILN_72 
912 |a GBV_ILN_120 
912 |a GBV_ILN_130 
912 |a GBV_ILN_227 
912 |a GBV_ILN_244 
912 |a GBV_ILN_285 
912 |a GBV_ILN_294 
912 |a GBV_ILN_350 
912 |a GBV_ILN_665 
912 |a GBV_ILN_813 
951 |a AR 
952 |d 60  |j 2022  |e 4  |b 02  |c 04  |h 345-349